Global22 May 2026 at 11:24 am

Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT

Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT
Global

Global Development Accelerates Further: Henlius' PD-L1 ADC HLX43 Completes First Patient Dosing in EU for Phase 2 MRCT

Article Details

Category: Global

Published: 22 May 2026

Time: 11:24 am

Author: Muhammad Sheikh

More Stories

Continue Reading

View Category

Stay Up To Date On The Latest News

By pressing the subscribe button, you confirm that you have read our privacy policy.